Literature DB >> 1671962

Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women.

M Soma, R Fumagalli, R Paoletti, M Meschia, M C Maini, P Crosignani, K Ghanem, J Gaubatz, J D Morrisett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1671962     DOI： 10.1016/0140-6736(91)91674-j

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Postmenopausal hormone replacement therapy.

Authors:  H S Jacobs; F E Loeffler
Journal:  BMJ       Date:  1992-12-05

Review 2.  Hormone replacement therapy in the aged. A state of the art review.

Authors:  S Jacobs; T C Hillard
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

Review 3.  Lipoprotein(a): A Lipoprotein Whose Time Has Come.

Authors:  Erik Kelly; Linda Hemphill
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-07

Review 4.  Cardiovascular pharmacology of hormone replacement therapy.

Authors:  G M Rosano; G Panina
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

5.  Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.

Authors:  C Sandholzer; E Boerwinkle; N Saha; M C Tong; G Utermann
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

6.  Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.

Authors:  D J Rader; W Cain; L A Zech; D Usher; H B Brewer
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

7.  Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma.

Authors:  P Henriksson; B Angelin; L Berglund
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

8.  Apolipoprotein (a) concentrations and susceptibility to coronary artery disease in patients with peripheral vascular disease.

Authors:  P Groves; A Rees; A Bishop; R Morgan; M Ruttley; N Lewis; I Lane; R Hall
Journal:  Br Heart J       Date:  1993-01

9.  Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes.

Authors:  J Ruiz; J Thillet; T Huby; R W James; D Erlich; P Flandre; P Froguel; J Chapman; P Passa
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

Review 10.  Lipoprotein(a): new insights into an atherogenic lipoprotein.

Authors:  W Bartens; C Wanner
Journal:  Clin Investig       Date:  1994-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.